Speaker: Dr Alex Lyon
In this video, Alex discusses his role as a Cardiologist in managing CML patients on a TKI (tyrosine kinase inhibitor). He reviews patients before, during and after treatment working in close communication and collaboration with the multi-disciplinary team with the underlying goal of keeping patients on treatment for as long as possible whilst minimising cardiovascular disease. He discusses recommended tests and interventions as well risk factors to be aware of.
Dr. Alex Lyon is a Senior Lecturer in Cardiology at Imperial College, London and a Consultant Cardiologist at the Royal Brompton Hospital. Alex has been the Clinical Lead for the cardio-oncology service at the Royal Brompton Hospital since 2011, specialising in surveillance and cardioprotection from modern cancer drugs, risk stratification and treatment of all cardiac complications of cancer treatment.
His clinical interests are in the fields of heart failure, cardio-oncology including chemotherapy cardiomyopathy and the cardiovascular complications of modern cancer therapies, Takotsubo syndrome and the effects of major stresses of the heart and the development of novel therapeutics including gene therapy for chronic heart failure. Alex has published 111 scientific papers in peer-reviewed journals and several book chapters in cardiovascular textbooks; he is an Associate Editor of the European Journal of Heart Failure.
Compare 2013 guidelines to those published in 2020
Interactive dosing guide with recommendations on how to approach dosing with Bosulif in different clincial scenarios
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2021 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?